scholarly journals Klebsiella pneumoniae-Induced Multiple Infections in a Diabetes Mellitus Patient: Pneumonia, Liver Abscess, Endogenous Endophthalmitis, Urinary Tract Infection

Reports ◽  
2018 ◽  
Vol 1 (1) ◽  
pp. 7
Author(s):  
Meng-Yu Wu ◽  
Yueh-Tseng Hou ◽  
Giou-Teng Yiang
Keyword(s):  
Diabetes Mellitus ◽  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Klebsiella Pneumoniae ◽  
Liver Abscess ◽  
Diabetes Mellitus Patient ◽  
Endogenous Endophthalmitis ◽  
Multiple Infections

scholarly journals Klebsiella pneumoniae associated nosocomial meningitis in a patient after resection of meningioma.

2015 ◽  
Vol 13 (1) ◽  
pp. 46-48
Author(s):  
Sabita Bhatta ◽  
Raina Chaudhary ◽  
Dhirendra Ayer
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Klebsiella Pneumoniae ◽  
Liver Abscess ◽  
Nosocomial Infections ◽  
Wound Infections ◽  
Healthy Individuals ◽  
Nosocomial Meningitis ◽  
Tract Infections

Klebsiella pneumoniae is a primary pathogen capable of causing urinary tract infection (UTIs), liver abscess and pneumonia in otherwise healthy individuals. However, most infections caused by K. pneumoniae are acquired in the hospitals and/or occur in those who are debilitated by various under lying conditions. Nosocomial infections caused by K. pneumoniae includes wound infections, infections of intravascular and other invasive devices, biliary tract infections, peritonitis and meningitis. We report a case of a 29 year old male who developed meningitis after excision of meningioma.doi: http://dx.doi.org/10.3126/mjsbh.v13i1.13004   

Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus

2019 ◽  
Vol 14 (2) ◽  
pp. 87-93 ◽  
Author(s):  
Mahakpreet Singh ◽  
Ruchika Sharma ◽  
Anoop Kumar
Keyword(s):  
Diabetes Mellitus ◽  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Diabetic Ketoacidosis ◽  
Adverse Drug Reactions ◽  
Sglt2 Inhibitor ◽  
Sglt2 Inhibitors ◽  
Drug Reactions ◽  
Authorization Holder

Background:Recently, Food and Drug Administration (FDA) has approved sodium/ glucose co-transporter 2 (SGLT2) inhibitors for the treatment of diabetes mellitus. However, regarding adverse drug reactions (ADRs) of SGLT2 inhibitors in large group of population, very less information is available. Thus, we have tried to find out the risk profile of SGLT2 inhibitors. Materials and Methods: A total of 1,042 studies have been published from Nov. 2012-Nov. 2017 regarding SGLT2 inhibitors. After inclusion and exclusion criteria, 27 studies have been selected for the analysis of risk. Results and Discussion:The emerging evidence indicates various adverse drug reactions such as foot and toe amputation, cancer, diabetic ketoacidosis, bone fracture risk and urinary as well as mycotic genital infection. The causality assessment has shown a correlation between SGLT2 inhibitors and diabetic ketoacidosis and urinary tract infection. Conclusion:In conclusion, Marketing Authorization Holder (MAH) and Regulatory Authorities (RA) should monitor various adverse drug reactions such as diabetic ketoacidosis and urinary tract infection with the use of SGLT2 inhibitor.

Multidrug-resistant mcr-1 gene-positive Klebsiella pneumoniae ST307 causing urinary tract infection in a cat

2021 ◽  
Author(s):  
Alessandra Tammy Hayakawa Ito de Sousa ◽  
Marco Túlio dos Santos Costa ◽  
Herica Makino ◽  
Stéfhano Luis Cândido ◽  
Isabela de Godoy Menezes ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Klebsiella Pneumoniae ◽  
Multidrug Resistant

Psoas abscess and bacterial peritonitis caused by urinary tract infection in a patient of liver cirrhosis and diabetes mellitus

2009 ◽  
Vol 2 (3) ◽  
pp. 242-245 ◽  
Author(s):  
Chiaki Kamikado ◽  
Shuuhei Taguchi ◽  
Tomomi Wakiyama ◽  
Akira Nakamura ◽  
Osamu Sawatani ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Urinary Tract Infection ◽  
Liver Cirrhosis ◽  
Urinary Tract ◽  
Tract Infection ◽  
Psoas Abscess ◽  
Bacterial Peritonitis

scholarly journals Isolation and diagnosis of bacteria causing urinary tract infection in pregnant and non pregnant females with diabetes mellitus type2

2019 ◽  
Vol 29 (4) ◽  
pp. 23
Author(s):  
Faraj Hatto Joni
Keyword(s):  
Diabetes Mellitus ◽  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Pregnant Women ◽  
Diabetic Patients ◽  
Microscopical Examination ◽  
Symptomatic Infection ◽  
Pregnant Females ◽  
Esherichia Coli

Diabetic patients have more outcomes of urinary tract infection than non diabetes, mortality of urinary tract infection (UTI) is 5 times higher in patients with diabetes old age, the incidence of urinary tract infection in pregnant women is slightly higher than non pregnant women, urinary tract infection in pregnant women either as a symptomatic bacteriiuria or symptomatic infection, which is more complication during pregnancy this present study was done in March 2016 to July 2016, the patients were females, total samples of 80 patient of pregnant and non pregnant with diabetes mellitus, selected from medical and general surgical wards, the samples were sending to teaching laboratories from the same hospital, the present study show that the incidence of UTI at non pregnant diabetic women occur at age (9-11) years (45%), the most common causative agents of UTI in diabetic pregnant females is Esherichia coli 20(50%), the results of microscopical examination of urine of pregnant with diabetes mellitus of urine of pregnant with diabetes mellitus revealed that (43), pyuria and (28) had crystals, and the result of microscopical examination of urine of non pregnant females with diabetes mellitus revealed that the common causative agent is Esherichia coli 3(30%), (9) had pyuria and (4) had crystals.

scholarly journals Fungal urinary tract infection in outpatient practice: approaches to diagnosis and treatment

2022 ◽  
pp. 138-142
Author(s):  
N. V. Sturov ◽  
S. V. Popov ◽  
I. Yu. Shmelkov
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Urinary Tract Infection ◽  
Type 2 Diabetes Mellitus ◽  
Candida Albicans ◽  
Urinary Tract ◽  
Tract Infection ◽  
Diagnosis And Treatment ◽  
Days Of Therapy

Introduction. In recent years, the role of fungal infection in inpatient and outpatient patients has been increasing. At the same time, there are currently no recommendations on the duration of treatment of outpatient patients with fungal urinary tract infection (UTI). Aim of the study. Optimization of methods of diagnosis and treatment of outpatient patients with fungal UTI.Materials and methods. To detect fungi in urine, the E. Koneman et al. (1997) method was improved. 56 patients with fungal UTI were examined. The efficacy of fluconazole in the treatment of fungal UTI was studied in 53 patients.Results. Candida albicans was detected in 37% of cases of fungal UTI in outpatient patients. Risk factors for fungal UTI in outpatient patients include: antibacterial therapy, infravesical obstruction, type 2 diabetes mellitus and the presence of urinary drainage. The microbiological efficacy of fluconazole therapy for 7, 10 and 14 days was 83.0%, 94.3% and 96.2%, respectively. The growth of fungi in the urine a month after treatment was absent in 86.7% of patients. In outpatient patients with fungal UTI without type 2 diabetes mellitus, the efficacy of fluconazole at a dose of 150 mg per day for 7 days was 94.9%. In patients with type 2 diabetes mellitus after 7 days of therapy, the efficacy was 50.0%.Conclusions. The most common causative agent of fungal UTI in outpatient patients is Candida albicans. To detect fungi in urine, samples should be seeded on selective media, while increasing the seeding volume to 0.1 ml and extending the incubation time to 96 hours. Fluconazole is a highly effective treatment for fungal UTI at a dose of 150 mg per day for 7 days, however, in patients with diabetes mellitus, therapy should last at least 10 days.

scholarly journals Prevalence of SUL(1,2), GYR(A, B) and OXA genes among multidrug resistance Klebsiella pneumoniae isolates recovered from women suffering urinary tract infection

2020 ◽  
Vol 11 (2) ◽  
pp. 2424-2432
Author(s):  
Nabil Salim Saaid Tuwaij ◽  
Huda Jameel Baker Al-khilkhali ◽  
Haneen Mohamed Mohsen
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Klebsiella Pneumoniae ◽  
Multidrug Resistant ◽  
Gram Negative ◽  
Gram Positive Bacteria ◽  
Vitek 2 ◽  
Resistant Microorganism ◽  
Urine Specimens

Klebsiella pneumoniae is a significant concern multidrug-resistant microorganism and a one common gram negative bacteria associated with infections of women urinary tract. Therefore, this work aimed to the molecular screening of Sul(1and 2), Gyr(A and B) and OXA genes among K. pneumoniae isolates in Najaf City, Iraq. Out of 250 urine specimens were collected from women showing symptoms of urinary tract infection during five months January to of May 2019, bacterial growth was157 isolates, included 133 gram negative compared with  24 gram positive bacteria while 98 specimens were no growth. According to the Vitek-2 system, 30 K. pneumoniae isolates were obtained.Data on current work revealed that the 26-35 age group was the highest 14 K. pneumoniae isolates. Results of antimicrobial susceptible recorded all isolates were multi-drug resistant (MDR) and they have a different range of resistance. However, all 30 isolates(100%) resistant to ampicillin drugs, while the lowest rate was 1(3.33%) forImipenemdrug. PCR assay revealed exist of oxa, sul-1, sul-2, gyr-A and gyr-B genes among K. pneumoniae isolates with rates 20(66.66%), 11(36.66%), 22(73.33%), 3(10%) and 17(56.66%) respectively.

Sign in / Sign up

Export Citation Format

Share Document